Secondary Logo

Journal Logo

October 1990 - Volume 9 - Issue 5
pp: 449-527

PDF Only


Limiting Dilution Analysis of Lymphokine-Activated Killer Cell Precursor Frequencies in Peripheral Blood Lymphocytes of Cancer Patients Receiving Interleukin-2 Therapy

Albertini, Mark R.; Oettel, Kurt R.; Weil-Hillman, Gilda; More

Journal of Biological Response Modifiers. 9(5):456-462, October 1990.

Separation and Growth of Human CD4+ and CD8+ Tumor-Infiltrating Lymphocytes and Peripheral Blood Mononuclear Cells by Direct Positive Panning on Covalently Attached Monoclonal Antibody-Coated Flasks

Morecki, Shoshana; Topalian, Suzanne L.; Myers, Warren W.; More

Journal of Biological Response Modifiers. 9(5):463-474, October 1990.

Initial Clinical Trial of the Macrophage Activator Muramyl Tripeptide-Phosphatidylethanolamine Encapsulated in Liposomes in Patients with Advanced Cancer

Creaven, Patrick J.; Cowens, Wayne J.; Brenner, Dean E.; More

Journal of Biological Response Modifiers. 9(5):492-498, October 1990.


PDF Only


Interferon-Alpha Maintenance Therapy After Cytotoxic Chemotherapy for Treatment of Acquired Immunodeficiency Syndrome-Related Kaposi's Sarcoma

Gill, Parkash S.; Rarick, Mark U.; Bernstein-Singer, Marjorie; More

Journal of Biological Response Modifiers. 9(5):512-516, October 1990.


PDF Only


A Phase II Trial of Recombinant Human Interferon-Gamma and Recombinant Tumor Necrosis Factor in Patients with Advanced Gastrointestinal Malignancies: Results of a Trial Terminated by Excessive Toxicity

Abbruzzese, James L.; Levin, Bernard; Ajani, Jaffer A.; More

Journal of Biological Response Modifiers. 9(5):522-527, October 1990.